跳至主要内容
临床试验/IRCT20230930059569N1
IRCT20230930059569N1招募中3 期

Evaluation of the effectiveness of topical formulation of Falcaria vulgaris extract in patients with vitiligo

Tabriz University of Medical Sciences0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with mild to moderate vitiligo
  • Patients who have at least two symmetric skin lesions
  • Not suffering from skin diseases, such as allergies, etc.
  • Not suffering from light-sensitive diseases such as lupus and porphyria,
  • Not using photosensitizing drugs such as retinoids
  • Patients who have not received systemic treatment for vitiligo in the past one month and during this period
  • Patients with lesions that are homogeneous in terms of size, location, and duration of the lesion, and stable so that the lesion did not spread for at least the last 6 months.

排除标准

  • Pregnancy and lactation
  • Patients with severe vitiligo
  • History of contact dermatitis
  • Having other skin diseases that affect the study
  • Patient dissatisfaction
  • Case of drug allergy
  • Face and axillary and inguinal region involvement
  • Mentally retarded patient

研究者

相似试验